NCT03262922

Brief Summary

The aim of the study is to compare the exposure to environmental and professional toxics by patients with systemic scleroderma and by patients not achieved by this pathology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
327

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 29, 2016

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 21, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 25, 2017

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2022

Completed
Last Updated

April 4, 2022

Status Verified

April 1, 2022

Enrollment Period

3.4 years

First QC Date

August 21, 2017

Last Update Submit

April 1, 2022

Conditions

Systemic Scleroderma

Keywords

systemic sclerodermaenvironmental and professional toxics

Outcome Measures

Primary Outcomes (1)

  • Questionnaire to evaluate the exposition of environmental and professional toxics

    clinical, personal and professional data

    once a year up to 2020

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with systemic scleroderma

You may qualify if:

  • Patients with systemic scleroderma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Rennes

Rennes, France

Location

MeSH Terms

Conditions

Scleroderma, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Study Officials

  • Patrick JEGO, Pr

    Rennes University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2017

First Posted

August 25, 2017

Study Start

July 29, 2016

Primary Completion

December 31, 2019

Study Completion

February 18, 2022

Last Updated

April 4, 2022

Record last verified: 2022-04

Locations

FR(1)